The PUMCH Dementia Cohort is a hospital-based, observational study of Chinese elderly with cognitive impairment.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The incidence of dementia
Timeframe: Through study completion,an average of 10-20 years
The relationship between lifestyles, stress (stressful events and their degree) and dementia
Timeframe: Through study completion,an average of 10 years
Risk factors for dementia
Timeframe: Through study completion,an average of 10-20 years
Cognitive decline
Timeframe: Through study completion,an average of 10-20 years
Functional decline
Timeframe: Through study completion,an average of 10-20 years
Changes in the Neuropsychiatric Index (NPI)
Timeframe: Through study completion,an average of 10 years
Changes in the Hospital Anxiety and Depression scale (HAD)
Timeframe: Through study completion,an average of 10 years
Changes in the Cornell Scale for dementia
Timeframe: Through study completion,an average of 10 years
Tau and Beta-amyloid biomarkers in CSF
Timeframe: Through study completion,an average of 10 years
Tau biomarkers in serum
Timeframe: Through study completion,an average of 10 years
CSF collection for assessing new dementia biomarker
Timeframe: Through study completion,an average of 10 years
Serum collection for assessing new dementia biomarker
Timeframe: Through study completion,an average of 10 years
Urine collection for assessing new dementia biomarker
Timeframe: Through study completion,an average of 10 years
Skin collection for assessing new dementia biomarker
Timeframe: Through study completion,an average of 10 years
Biomarker differences of dementia
Timeframe: Through study completion,an average of 10 years
Incorporating age stratified biomarkers into the diagnosis of dementia
Timeframe: Through study completion,an average of 10 years
Dementia education and training
Timeframe: Through study completion,an average of 10 years
Dementia diagnosis system and evaluation system
Timeframe: Through study completion,an average of 10 years